Bruker Corporation Price, Consensus and EPS Surprise Bruker Corporation price-consensus-eps-surprise-chart | Bruker Corporation ... driven by both the MALDI Biotyper and the newly acquired ELITech ...

driven by both the MALDI Biotyper and the newly acquired ELITech Molecular Diagnostics business, as well as the Optics IR, near IR and Raman molecular spectroscopy business. This year, Bruker ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat. Bruker ...

BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — Bruker Corp. (BRKR) on Thursday reported fourth-quarter earnings of $13.7 million. The Billerica, Massachusetts-based company said it had profit ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...